2021
DOI: 10.1016/j.adro.2021.100691
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Postoperative Radiation Therapy Timing on Survival in Pediatric and Young Adult Ependymoma

Abstract: Postoperative radiation therapy (RT) is commonly used for World Health Organization grade II-III intracranial ependymoma. Clinicians generally aim to begin RT ≤5 weeks after surgery, but postoperative recovery and need for second look surgery can delay the initiation of adjuvant therapy. On ACNS 0831, patients were required to enroll ≤8 weeks after initial surgery and begin adjuvant therapy within 3 weeks after enrollment. The purpose of this study was to determine the optimal timing of RT after surgery. Metho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
(60 reference statements)
0
1
0
Order By: Relevance
“…Radiotherapy should extend 1cm beyond the tumor bed, with a total dose between 54-59.4Gy (3,28,41). Shah et al analyzed the impact of adjuvant radiotherapy for pediatric ependymomas and showed that the time to initiation of therapy after surgery, the total dose, and the age of the patients did not alter overall survival, and delay could be accepted in case of clinical complications (42). This reinforces the importance of radiotherapy in the treatment of ependymomas, but does not mean cases without clinical complications can tolerate delays in starting radiotherapy.…”
Section: Treatments and Outcomesmentioning
confidence: 99%
“…Radiotherapy should extend 1cm beyond the tumor bed, with a total dose between 54-59.4Gy (3,28,41). Shah et al analyzed the impact of adjuvant radiotherapy for pediatric ependymomas and showed that the time to initiation of therapy after surgery, the total dose, and the age of the patients did not alter overall survival, and delay could be accepted in case of clinical complications (42). This reinforces the importance of radiotherapy in the treatment of ependymomas, but does not mean cases without clinical complications can tolerate delays in starting radiotherapy.…”
Section: Treatments and Outcomesmentioning
confidence: 99%